TY - JOUR
T1 - The effect of general anesthesia on the intestinal lymphatic transport of lipophilic drugs
T2 - Comparison between anesthetized and freely moving conscious rat models
AU - Dahan, Arik
AU - Mendelman, Avivit
AU - Amsili, Sofia
AU - Ezov, Nathan
AU - Hoffman, Amnon
N1 - Funding Information:
This study was supported by the Israeli Consortium of Pharmalogica. The authors thank Ms. Sarit Greenberg for excellent technical assistance, and Dr. Josh Backon for constructive comments. A. Hoffman is affiliated with David R. Bloom Center of Pharmacy.
PY - 2007/12/1
Y1 - 2007/12/1
N2 - The purpose of this study was to evaluate the impact of general anesthesia on the lymphatic transport of orally administered drugs. Vitamin D3 (0.5 mg/kg), a model lipophilic molecule with significant lymphatic transport, was administered to anesthetized rats in close proximity to the lymphatic cannulation procedure. The lymphatic and non-lymphatic absorption of the vitamin in this experimental model was compared to lymph-duct cannulated freely moving conscious rats. The amounts of vitamin D3 transported via the lymph in the anesthetized animals throughout the time frame of this experimental model (8 h) were 25% lower as compared to the conscious animals, but showed similar absorption kinetics. However, the duration of the anesthesia is limited and thus failed to produce the complete picture of the absorption process. The cumulative percent of the vitamin dose that was recovered in the lymph as well as the vitamin plasma AUC values were both 25% lower in the anesthetized animals as compared to the conscious animals. Hence, the anesthesia did not influence the proportion of the vitamin fraction absorbed via the different pathways. The lymph flow rate was significantly decreased by the anesthesia (threefold), however, higher lymph vitamin concentrations in these animals led to lower differences in the vitamin lymphatic transport (25%) between the models. In conclusion, the anesthetized rat model is suitable for approximating the lymphatic transport. However, the conscious rat model is still required in order to have a more precise and complete measurement of lymphatic transport.
AB - The purpose of this study was to evaluate the impact of general anesthesia on the lymphatic transport of orally administered drugs. Vitamin D3 (0.5 mg/kg), a model lipophilic molecule with significant lymphatic transport, was administered to anesthetized rats in close proximity to the lymphatic cannulation procedure. The lymphatic and non-lymphatic absorption of the vitamin in this experimental model was compared to lymph-duct cannulated freely moving conscious rats. The amounts of vitamin D3 transported via the lymph in the anesthetized animals throughout the time frame of this experimental model (8 h) were 25% lower as compared to the conscious animals, but showed similar absorption kinetics. However, the duration of the anesthesia is limited and thus failed to produce the complete picture of the absorption process. The cumulative percent of the vitamin dose that was recovered in the lymph as well as the vitamin plasma AUC values were both 25% lower in the anesthetized animals as compared to the conscious animals. Hence, the anesthesia did not influence the proportion of the vitamin fraction absorbed via the different pathways. The lymph flow rate was significantly decreased by the anesthesia (threefold), however, higher lymph vitamin concentrations in these animals led to lower differences in the vitamin lymphatic transport (25%) between the models. In conclusion, the anesthetized rat model is suitable for approximating the lymphatic transport. However, the conscious rat model is still required in order to have a more precise and complete measurement of lymphatic transport.
KW - Anesthetization
KW - Lipophilic drugs
KW - Lymphatic transport
KW - Oral bioavailability
KW - Vitamin D
UR - http://www.scopus.com/inward/record.url?scp=35748959920&partnerID=8YFLogxK
U2 - 10.1016/j.ejps.2007.09.005
DO - 10.1016/j.ejps.2007.09.005
M3 - Article
AN - SCOPUS:35748959920
SN - 0928-0987
VL - 32
SP - 367
EP - 374
JO - European Journal of Pharmaceutical Sciences
JF - European Journal of Pharmaceutical Sciences
IS - 4-5
ER -